Corporate Information

Corporate Overview

Developing innovative treatment methods and creating new value

Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage.
We will do what it takes to offer patients new innovative treatment choices and stand true to the Otsuka corporate philosophy; “Otsuka—people creating new products for better health worldwide.”


Company Name Otsuka Medical Devices Co., Ltd.
Established February 15th, 2011
Capital 7.55 billion yen
Head Office 2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048, Japan
Tokyo Headquarters Shinagawa Grand Central Tower 13F
2-16-4, Konan, Minato-ku, Tokyo 108-0075, Japan [Location]
Employees 99 (As of December 31, 2021)
Business Activities Overseeing medical device operations within the Otsuka group and the business activities of companies engaged in related businesses, as well as all operations incidental to the foregoing activities.
Shareholder Otsuka Holdings Co., Ltd. (100%)

Board of Directors

President and Representative Director Noriko Tojo
Executive Deputy President Kazumichi Kobayashi
Executive Director Yoshiro Matsuo
Executive Director Kuniaki Natsume
Outside Director Tomiko Tawaragi
Statutory Auditor Yasuhiro Gomi
Outside Audit & Supervisory Board Member Naoki Miyamori

(As of March 8, 2022)

Otsuka Medical Devices Group Members

Back to top
Copyright (C) Otsuka Medical Devices Co., Ltd.